Abstract
This study aimed to evaluate the hematoprotective effects of eugenol against iron overload in male rats. A total of 30 rats were randomly divided into six equal groups as follows: the control negative (C-) group I.P injection distal water. The control positive (C+) group received iron dextran (100 mg/kg-BW) I.P injection. The IE1 and IE2 groups received iron dextran 100 mg/kg-BW I.P and eugenol (50,100 mg/kg-BW) orally, respectively, and the E3 and E4 groups received eugenol (50,100 mg/kg-BW) orally. After 30 days of the experiment, the blood was collected to measure the experimental parameters. The results demonstrated a significant increase in RBCs, Hb percentage, WBCs, PCV, and PTL in the C+ group compared to the C- group. Also, there was a non-significant difference between IE1 and C+ in RBCs and Hb. Meanwhile, PCV decreased significantly in IE1 compared with C+. Conversely, the C+ group showed decreased MCV compared with IE1. Microscopic examination of blood smears indicated normal red blood cell morphology in the C- and iron dextran with eugenol-treated groups, while the C+ group exhibited microcytic hypochromic morphology. In conclusion, the ameliorative effect of eugenol against iron overload-induced hematotoxicity is achieved by restoring the hematological parameters near the normal control.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
